| Intuniv 4 mg prolonged-release tablets EU/1/15/1040/008-009 |
GUANFACINE HYDROCHLORIDE |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| LIVTENCITY 200 mg film-coated tablets EU/1/22/1672/001-002 |
Maribavir |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Mezavant XL 1200 mg gastro-resistant, prolonged release tablets PA23211/004/001 |
Mesalazine |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| NINLARO 2.3 mg hard capsules EU/1/16/1094/001 |
Ixazomib citrate |
Takeda Pharma A/S |
— |
| NINLARO 3 mg hard capsules EU/1/16/1094/002 |
Ixazomib citrate |
Takeda Pharma A/S |
— |
| NINLARO 4 mg hard capsules EU/1/16/1094/003 |
Ixazomib citrate |
Takeda Pharma A/S |
— |
| PANTOZOL Control 20 mg Gastro-resistant tablet EU/1/09/517/001-004 |
Pantoprazole sodium sesquihydrate |
Takeda GmbH |
— |
| Plenadren 20 mg modified-release tablets EU/1/11/715/002 |
Hydrocortisone |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Plenadren 5 mg modified-release tablets EU/1/11/715/001 |
Hydrocortisone |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| PROSTAP 3 DCS 11.25 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/001 |
Leuprorelin acetate |
Takeda Products Ireland Ltd |
Marketed |
| PROSTAP 6 DCS 30 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/002 |
Leuprorelin acetate |
Takeda Products Ireland Ltd |
Marketed |
| PROSTAP SR DCS 3.75 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/003 |
Leuprorelin acetate |
Takeda Products Ireland Ltd |
Marketed |
| Protium 20 mg gastro-resistant tablets PA2229/010/001 |
Pantoprazole sodium sesquihydrate |
Takeda Products Ireland Ltd |
Marketed |
| Protium 40 mg gastro-resistant tablets PA2229/010/002 |
Pantoprazole |
Takeda Products Ireland Ltd |
Marketed |
| Protium i.v. 40 mg Powder for Solution for Injection PA2229/010/003 |
Pantoprazole |
Takeda Products Ireland Ltd |
Marketed |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/001 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/002 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/003 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/004 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Replagal 1 mg/ml concentrate for solution for infusion EU/1/01/189/001 |
Agalsidase alfa |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Resolor 1 mg film-coated tablets EU/1/09/581/001 |
Prucalopride Succinate |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Resolor 2 mg film-coated tablets EU/1/09/581/002 |
Prucalopride Succinate |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Revestive 1.25 mg powder and solvent for solution for injection EU/1/12/787/003 |
Teduglutide |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Revestive 5 mg powder and solvent for solution for injection EU/1/12/787/001 |
Teduglutide |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| SOMAC Control 20 mg Gastro-resistant tablet EU/1/09/516/001-004 |
Pantoprazole sodium sesquihydrate |
Takeda GmbH |
— |
| TAKHZYRO 150 mg solution for injection in pre-filled syringe EU/1/18/1340/007-009 |
LANADELUMAB |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| TAKHZYRO 300 mg solution for injection EU/1/18/1340/001 |
LANADELUMAB |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Tyvense 20 mg capsules, hard PA23211/005/001 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 30 mg capsules, hard PA23211/005/002 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 40 mg capsules, hard PA23211/005/003 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 50 mg capsules, hard PA23211/005/004 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 60 mg capsules, hard PA23211/005/005 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 70 mg capsules, hard PA23211/005/006 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Vipdomet 12.5 mg/1000 mg film-coated tablets EU/1/13/843/013-024 |
Alogliptin (as benzoate), Metformin Hydrochloride |
Takeda Pharma A/S |
— |
| Vipdomet 12.5 mg/850 mg film-coated tablets EU/1/13/843/001-012 |
Metformin Hydrochloride, Alogliptin (as benzoate) |
Takeda Pharma A/S |
— |
| Vipidia 12.5 mg film-coated tablets EU/1/13/844/010-018 |
Alogliptin (as benzoate) |
Takeda Pharma A/S |
— |
| Vipidia 25 mg film-coated tablets EU/1/13/844/019-027 |
Alogliptin (as benzoate) |
Takeda Pharma A/S |
— |
| Vipidia 6.25 mg film-coated tablets EU/1/13/844/001-009 |
Alogliptin (as benzoate) |
Takeda Pharma A/S |
— |
| Xagrid 0.5 mg hard capsules EU/1/04/295/001 |
Anagrelide hydrochloride |
Takeda Pharmaceuticals International AG Ireland Branch |
— |